114 results on '"MacNee, William."'
Search Results
2. Purpose of the Conference: The 2017 Transatlantic Conference on Lung Diseases
3. Hospitalized Exacerbations of COPD: Risk Factors and Outcomes in the ECLIPSE Cohort
4. Association Between Interstitial Lung Abnormalities and All-Cause Mortality
5. Purpose of the Conference: 2015 Transatlantic Airway Conference
6. British Thoracic Society guidelines for home oxygen use in adults
7. British Thoracic Society guidelines for home oxygen use in adults
8. One-year change in health status and subsequent outcomes in COPD
9. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease
10. Poor Symptom Control Is Associated With Reduced CT Scan Segmental Airway Lumen Area in Smokers With Asthma
11. Identification of Five Chronic Obstructive Pulmonary Disease Subgroups with Different Prognoses in the ECLIPSE Cohort Using Cluster Analysis
12. Purpose of the Conference
13. Common Genetic Variants Associated with Resting Oxygenation in Chronic Obstructive Pulmonary Disease
14. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality
15. Lessons from ECLIPSE: a review of COPD biomarkers
16. Should We View Chronic Obstructive Pulmonary Disease Differently after ECLIPSE?. A Clinical Perspective from the Study Team
17. HELPING PEOPLE WITH VERY SEVERE COPD: FEASIBILITY STUDY OF A NOVEL HOLISTIC INTERVENTION
18. Quantitative Computed Tomography Measures of Pectoralis Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease. A Cross-Sectional Study
19. Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease: Do They Influence Patient-Related Outcomes?
20. Purpose of the Conference
21. The Search for Distinct and Clinically Useful Phenotypes in Chronic Obstructive Pulmonary Disease
22. Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial
23. Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease
24. Brain Natriuretic Peptide Measurement in Patients With COPD and Cardiovascular Disease
25. Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
26. The COPD control panel: towards personalised medicine in COPD
27. Authors response. The chronic obstructive pulmonary disease (COPD) control panel: towards personalised medicine in COPD
28. Cardiovascular Disease in COPD: Mechanisms
29. Six-Minute-Walk Test in Chronic Obstructive Pulmonary Disease: Minimal Clinically Important Difference for Death or Hospitalization
30. Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases: A “Vulnerable” Relationship
31. Genome-Wide Association Analysis of Blood Biomarkers in Chronic Obstructive Pulmonary Disease
32. A Guide to Guidelines for Professional Societies and Other Developers of Recommendations: Introduction to Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report
33. Deciding What Type of Evidence and Outcomes to Include in Guidelines: Article 5 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report
34. Priority Setting in Guideline Development: Article 2 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report
35. Abnormal Lung Aging in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
36. The Threshold Length for Fiber-Induced Acute Pleural Inflammation: Shedding Light on the Early Events in Asbestos-Induced Mesothelioma
37. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease
38. Purpose of the Conference
39. Systemic elastin degradation in chronic obstructive pulmonary disease
40. Antioxidant pharmacological therapies for COPD
41. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease
42. Zeta Potential and Solubility to Toxic Ions as Mechanisms of Lung Inflammation Caused by Metal/Metal Oxide Nanoparticles
43. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13
44. Aging, Inflammation, and Emphysema
45. Purpose of the Conference
46. Changes in Forced Expiratory Volume in 1 Second over Time in COPD
47. Clinic Practice Guidelines: More of the Same?
48. Increased platelet activation in patients with stable and acute exacerbation of COPD
49. Serum PARC/CCL-18 Concentrations and Health Outcomes in Chronic Obstructive Pulmonary Disease
50. Human Models of Exacerbations of COPD: No Extrapolation Needed
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.